Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA01 - Improving Outcomes in Locoregional NSCLC I
- 10:30 - 12:00
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
OA01.07 - Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC
11:35 - 11:45 | Presenter: Greg Durm | Author(s): Sandra Althouse, Ahad Sadiq, Shadia Jalal, Salma Jabbour, Robin Zon, Goetz H Kloecker, William Fisher, Karen L. Reckamp, Ebenezer Kio, Robert Langdon, Bamidele Adesunloye, Ryan Gentzler, Nasser Hanna
- Abstract
Loading...
-
+
MA04 - Novel Approaches with IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA04.09 - Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
14:30 - 14:35 | Presenter: Valerie W Rusch | Author(s): Jamie E Chaft, Bruce E Johnson, Ignacio I. Wistuba, Mark G Kris, Jay M Lee, Paul A. Bunn, Jr., David J Kwiatkowski, Karen L. Reckamp, David J. Finley, Eric B. Haura, Saiama N. Waqar, Robert C. Doebele, Edward B Garon, Justin Blasberg, Alan Nicholas, Katja Schulze, See Phan, Mayank Gandhi, David P Carbone
- Abstract
Loading...
-
+
PC04 - Targeted Therapy for NSCLC
- 15:15 - 16:45
- 9/24/2018
- Location: Room 106
- Type: Pro-Con Session
- Track: Targeted Therapy
-
+
PC04.02 - Optimal Sequencing of EGFR TKI Therapy - 3rd Generation First
15:27 - 15:39 | Presenter: Karen L. Reckamp
- Abstract
No abstract available for this presentation
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- 15:15 - 16:45
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA12.07 - Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
16:20 - 16:30 | Presenter: Geoffrey R. Oxnard | Author(s): Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-06 - HSP72 Expression Associates with Survival in EGFR Mutated NSCLC
16:45 - 18:00 | Presenter: Idoroenyi Amanam | Author(s): Paul Frankel, Stephanie Mach, Emily Dickinson, Li Zheng, Binghui Shen, Karen L. Reckamp
- Abstract
Loading...